Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel cysteine protease inhibitors discussed by BASF

Aug. 24, 1998

HemispheRx announces first regulatory filing for CFS/ME treatment agent

Aug. 21, 1998

LY-341495 proves to be a potent tool in the study of metabotropic glutamate receptor function

Aug. 21, 1998

First application of Medtronic's neurostimulator in two patients with Parkinson's disease

Aug. 21, 1998

Yoshitomi claims safe and effective new antipsychotic agents

Aug. 21, 1998

Vertex solves 3D structure of JNK3, an enzyme implicated in epilepsy and stroke

Aug. 21, 1998

Available from NIH: compounds for the treatment of CNS disorders

Aug. 20, 1998

Zeldox development strategy disclosed

Aug. 20, 1998

Key U.S. patent issued for Emitasol

Aug. 20, 1998

GVS-111, a novel cognition-enhancing agent with a multifaceted mechanism of action

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...